News and Insights

Patient assistance programs (or PAPs) are generally sponsored by pharmaceutical manufacturers to provide free drug or financial assistance to patients who are uninsured or underinsured. Patients who qualify for patient assistance programs can receive medication for little or no cost, helping the most in-need patients gain access to therapy if...

AssistRx President and CEO Jeff Spafford lent his voice to Drug Channels—one of the industry's leading publications offering expert insights on pharmaceutical economics and the drug distribution system—to weigh in on how to combat the gross-to-net squeeze and increased competition with a technology-driven pharmacy platform that removes barriers to access,...

Several studies have found that as a patient’s out-of-pocket cost share rises, primary adherence—or the patient’s first prescription fill and use as prescribed—drops significantly. According to IQVIA Institute for Human Data Science’s “Report: Medicine Spending and Affordability in the United States” released in August 2020, prescription abandonment rates are less...

Pharmaceutical Commerce, a publication written for biopharma commercial executive decision-makers focusing on business processes and the technologies involved in how approved drugs go to market, included AssistRx in its March 2021 Hubs and Patient Support issue.In "Today's hub blueprint: Lock in on the journey," AssistRx Patient Solutions Division President Jan...

iAssist is the most comprehensive therapy initiation platform available to healthcare providers. One of the platform’s most utilized and impactful solutions is real-time electronic prior authorization. The iAssist platform provides automated, pre-populated prior authorization forms that guide the user through the prior authorization submission process, returning determinations within minutes to...